Stocks · Health care · Pharmaceutical Preparations

Greenwich LifeSciences, Inc.

GLSI Clue Score23
United States Fiscal year ends December CIK 0001799788

What the insiders did No buying or selling

By person

2 insiders · 0 transactions
100×

Snehal Patel holds 100 times base salary in stock. $73.51M of shares against $735.08K in salary for 2025.

Salary from the company's own proxy. The shares are what Snehal Patel last reported holding, valued at $13.10, the price Common Stock was last bought or sold at on the open market here, on 29 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Snehal Patel
CEO and CFO
—
—
—
5,611,402
$73.51M
+1.4%
Jaye Thompson
VP Clinical Reg Affairs
—
—
—
264,148
$3.46M
+0.4%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.